The usability of MCP-1, fetuin-A, TAS, and TOS levels in the diagnosis of acute myocardial infarction
Yazarlar (8)
H. Ciftci University of Health Sciences, Türkiye
H. F. Gul Kafkas Üniversitesi, Türkiye
O. Canacik Memorial Sisli Hospital, Türkiye
T. Dolanbay Niğde Ömer Halisdemir University, Türkiye
E. Karsli Tınaztepe University, Türkiye
D. Ercin Seka State Hospital, Türkiye
L. Sahin
Kafkas Üniversitesi, Türkiye
Prof. Dr. Mahmut KARAPEHLİVAN Kafkas Üniversitesi, Türkiye
Devamını Göster...
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı European Review for Medical and Pharmacological Sciences (Q2)
Dergi ISSN 1128-3602 Dergi Bilgileri (2023)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2023
Cilt / Sayı / Sayfa 27 / 10 / 4481–4491 DOI 10.26355/eurrev_202305_32454
Makale Linki https://www.europeanreview.org/wp/wp-content/uploads/4481-4491.pdf
UAK Araştırma Alanları
Tıbbi Biyokimya
Özet
OBJECTIVE: Our aims were to determine whether the levels of plasma monocyte chemotactic protein-1 (MCP-1), fetuin-A, serum total antioxidant status (TAS), and serum total oxidant status (TOS) are cardiac biomarkers and to clarify their relationship with each other in acute myocardial infarction (AMI). PATIENTS AND METHODS: The study included 90 participants: 60 patients with AMI [30 with and 30 without ST-segment elevation myocardial infarction (STEMI)] and 30 cardiac patients without AMI. The diagnostic values of serum Hs-cTnT, MCP-1, fetuin-A, TAS, and TOS levels in predicting AMI were evaluated statistically. RESULTS: Median levels of MCP-1 [120.10 ng/L (interquartile range: 76.94-230.54 ng/L)] and TOS [2.89 U/MI (IQR: 2.31-3.94 U/Ml)] were statistically higher, and median levels of fetuin- A [433.52 mg/L (IQR: 387.89-584.49 mg/L)] and TAS (3.10 ± 0.86 U/mL) were lower in patients with AMI than in controls. The parameter with the area under the curve (0.815), sensitivity (73.3%), and specificity (66.7%) closest to those of Hs-cTnT was fetuin-A, followed by MCP-1, TOS, and TAS, respectively. A one-unit increase in MCP-1 levels increased the probability of AMI by 1.023 times (p = 0.002). A one-unit increase in fetuin-A levels decreased the probability of AMI by 0.995 times (p = 0.003). A one-unit increase in serum TOS levels was 1.29 times more characteristic of STEMI than of NSTEMI (p = 0.044). CONCLUSIONS: MCP-1, oxidative stress parameters, and fetuin-A might support Hs-cTnT levels in the early diagnosis of AMI. Fetuin-A and MCP-1 levels may be independent risk factors for AMI, whereas TOS could be used to distinguish STEMI from NSTEMI.
Anahtar Kelimeler
Cardiac biomarker | Myocardial infarction | Oxidative stress parameter
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Scopus 4
Google Scholar 8
PubMed 3
The usability of MCP-1, fetuin-A, TAS, and TOS levels in the diagnosis of acute myocardial infarction